Loading...
Email Alert | RSS

Table of Content

    10 October 2024, Volume 46 Issue 10
    Anniversary Commemorative Section
    Anniversary Commemorative Section The imprint of tuberculosis prevention and control history in Chinese Journal of Antituberculosis
    Wang Lixia, Jiang Shiwen, Liu Yuhong, Zhu Xiaoli
    Chinese Journal of Antituberculosis. 2024, 46(10):  1123-1140.  doi:10.19982/j.issn.1000-6621.20240380
    Abstract ( 144 )   HTML ( 24 )   PDF (1586KB) ( 368 )   Save
    References | Related Articles | Metrics
    Review and prospect of the 90th anniversary of the founding of the Chinese Journal of Antituberculosis
    Guo Meng, Li Jingwen, Fan Yongde, Meng Li, Wang Ran, Yang Ying
    Chinese Journal of Antituberculosis. 2024, 46(10):  1141-1153.  doi:10.19982/j.issn.1000-6621.20240359
    Abstract ( 158 )   HTML ( 25 )   PDF (9276KB) ( 327 )   Save
    Figures and Tables | References | Related Articles | Metrics

    In 2024, the Chinese Journal of Antituberculosis ushered in its 90th anniversary. In its long course of development, it faithfully recorded the founding, development and prosperity of tuberculosis prevention and control in China. This article reviewed the development of the Chinese Journal of Antituberculosis in the past 90 years, showed the achievements in recent years, and looked forward to the future development. It is believed that the journal can continue to make greater contributions to the “End Tuberculosis Strategy” in China.

    Analysis of publication status and changes in main evaluation indicators of the Chinese Journal of Antituberculosis from 2014 to 2023
    Guo Meng, Li Jingwen, Fan Yongde, Meng Li, Wang Ran, Yang Ying
    Chinese Journal of Antituberculosis. 2024, 46(10):  1154-1165.  doi:10.19982/j.issn.1000-6621.20240355
    Abstract ( 169 )   HTML ( 18 )   PDF (2433KB) ( 210 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the changes of publication and main evaluation indicators of the Chinese Journal of Antituberculosis from 2014 to 2023, and provide reference for sustainable development of the journal. Methods: Academic papers published in the Chinese Journal of Antituberculosis from 2014 to 2023 were searched through the Wanfang database. Descriptive analysis was used to calculate the number of authors, publishing institutions, citations, as well as the core authors and their institutions for each year of 2014 to 2023, and to illustrate statistics on high cited papers and high publishing institutions in the Chinese Journal of Antituberculosis from 2014 to 2023. Results: From 2014 to 2023, the Chinese Journal of Antituberculosis published a total of 2310 articles, with an average of 5.40 authors per article and an average of 7.78 citations per article. According to statistics of the core authors of this journal, Cheng Jun, Deng Guofang, Jiang Shiwen, Liu Eryong, and Chen Hui were the top five first authors in terms of comprehensive academic level, with comprehensive academic level values of 535.56, 500.89, 487.85, 455.92, and 430.65, respectively; Xiao Heping, Zhao Yanlin, Wu Xueqiong, Qin Shibing, and Zhang Hui were the top five corresponding authors in terms of comprehensive academic level, with comprehensive academic level values of 843.28, 702.64, 534.17, 491.83, and 430.78, respectively. Beijing Chest Hospital affiliated to Capital Medical University, National Center for Tuberculosis Control and Prevention of the Chinese Center for Disease Control and Prevention, and Shanghai Pulmonary Hospital affiliated to Tongji University were institutions with highest numbers of articles published by Chinese Journal of Antituberculosis during this period, with 350, 155, and 101 articles respectively. Conclusion: The articles in the Chinese Journal of Antituberculosis have been cited at a relatively high level, but there is still room for improvement. Strengthening cooperation with high publishing institutions, attracting more core authors, and establishing extensive connections with experts, scholars, readers, and authors in the field are important ways for journals to achieve sustainable development.

    Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China
    Ruan Yunzhou, Su Wei, Zhang Hui, Zhao Yanlin
    Chinese Journal of Antituberculosis. 2024, 46(10):  1166-1170.  doi:10.19982/j.issn.1000-6621.20240336
    Abstract ( 196 )   HTML ( 32 )   PDF (1358KB) ( 257 )   Save
    References | Related Articles | Metrics

    Rifampicin-resistant tuberculosis (RR-TB) is a major public health problem facing in China. How to control and prevent drug-resistant tuberculosis and reduce its harm to society and the public, the author comprehensively reviewed the historical evolution of drug-resistant tuberculosis control and prevention in China from three stages: exploration and research, planning and implementation, and comprehensive promotion. From the exploration of nothing, to the innovative establishment of a new model for drug-resistant tuberculosis control and prevention and the results achieved. At the same time, in response to the challenges of high rifampicin-resistance rate with retreated patients and unsatisfactory treatment success rate of among patients undergoing treatment in China, the author also puts forward suggestions and prospects for the next steps for your reference.

    Research advances and breakthroughs in tuberculosis vaccine
    Li Junli, Guo Xiaonan, Liang Yan, He Pu, Li Xiaochi, Zhao Aihua, Du Weixin, Wu Xueqiong, Zhu Bingdong, Xu Miao
    Chinese Journal of Antituberculosis. 2024, 46(10):  1171-1184.  doi:10.19982/j.issn.1000-6621.20240296
    Abstract ( 222 )   HTML ( 25 )   PDF (1885KB) ( 2779 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Tuberculosis (TB) is an enduring infectious disease caused by Mycobacterium tuberculosis (MTB), presenting a significant threat to human health. Its primary mode of transmission is through respiratory pathways, with pulmonary tuberculosis being predominant. Currently, bacillus Calmette-Guérin (BCG) remains the only widely used prophylactic TB vaccination globally; playing a crucial role in protecting infants and young children from TB onset. Nevertheless, due to its limited long-term protection and incapacity to prevent latent tuberculosis infection (LTBI), its impact on curtailing MTB spread within society at large is constrained. Researchers worldwide are actively exploring diverse technological avenues for novel TB vaccinations that extend beyond the conventional BCG framework. This review comprehensively examines recent progress in domestic and international research on novel approaches for combating TB through vaccination while outlining groundbreaking developments involving antigen screening methods, innovative vaccine platforms, and precision-focused immunization strategies—providing valuable insights for future efforts related to anti-tuberculosis vaccinations.

    Special Topic
    China can eliminate tuberculosis
    Daniel P. Chin, Zheng Zhijie
    Chinese Journal of Antituberculosis. 2024, 46(10):  1185-1187.  doi:10.19982/j.issn.1000-6621.20240310
    Abstract ( 244 )   HTML ( 24 )   PDF (1244KB) ( 167 )   Save
    References | Related Articles | Metrics

    China is currently not on track to achieve the tuberculosis (TB) targets of the 2030 Sustainable Development Goals even though the country is detecting and successfully treating more than 70% of its incident TB cases each year. Based on recent scientific understanding and evidence, achieving these targets are possible if the TB control approach shifts from purely “passive detection” to include large-scale “active screening”. China has an unprecedented opportunity to scale up “active screening” because the diagnostic technology and infrastructure for active screening are largely or will soon be in place, including the availability of tongue swab-based molecular tests and AI-assisted imaging of X-ray and CT images. By seizing this opportunity, China can be the first high TB-burden country to reduce TB incidence by 80% and eliminate TB as a major public health problem in 2030.

    Significance and challenges of the implementation of PAN-TB treatment strategy for tuberculosis prevention and control
    Sha Wei
    Chinese Journal of Antituberculosis. 2024, 46(10):  1188-1192.  doi:10.19982/j.issn.1000-6621.20240316
    Abstract ( 146 )   HTML ( 15 )   PDF (1314KB) ( 140 )   Save
    Figures and Tables | References | Related Articles | Metrics

    The control of drug-resistant tuberculosis (TB) globally still faces huge challenges. The PAN-TB regimen is a first-line regimen suitable for all forms of TB, which means that it should be initiated immediately upon confirmation of active TB disease, without waiting for the patient’s drug resistance status. The goal of implementing the PAN-TB regimen is to initiate effective treatment as soon as possible, reduce transmission, and significantly simplify the complexity of TB program management. It is not only a clinical treatment method, but also a public health measure. This article defines the definition, requirements, global research progress, and significance for TB control of the PAN-TB strategy, with the aim of providing new ideas for the prevention and control of TB in China.

    Practice and thoughts on the construction of “Zero TB City” in Huzhou City, Zhejiang Province
    Zheng Pingming, Jin Meihua, Ding Zhongming, Wen Dong, Ren Feilin, Liu Xiaoqi, Lyu Xin, Chen Haiyan, Li Zhiguo, Shao Bin, Wang Wei
    Chinese Journal of Antituberculosis. 2024, 46(10):  1193-1197.  doi:10.19982/j.issn.1000-6621.20240142
    Abstract ( 231 )   HTML ( 21 )   PDF (1297KB) ( 368 )   Save
    References | Related Articles | Metrics

    Tuberculosis (TB) is an infectious disease that seriously endangers human health and is listed as one of the major infectious diseases in China. The Government of Huzhou City, Zhejiang Province has attached great importance to the prevention and control of TB for all time. By implementing various prevention and control measures, and continuously exploring innovative demonstrative measures, promoting steady decline of TB notification incidence in the city, the notification incidence of Huzhou always stays lower than the average level of Zhejiang Province. On the basis of establishing “Zero TB Community”, Huzhou City proposed to construct a “Zero Tuberculosis City” as the first one in China in 2023, to explore and implement new strategies and measures to accelerate the decline of TB epidemic, and strive to provide a practical model for achieving the goal of Ending TB Strategy. This paper discusses the main practices and considerations of the construction of “Zero TB City” in Huzhou City, provides a reference for ending TB work in TB low prevalence area.

    Original Articles
    Analysis of the epidemiological characteristics of national reported pulmonary tuberculosis incidence, 1997—2023
    Song Yuanyuan, Li Tao, Xia Hui, Zhang Lijie, Zhang Hui, Zhao Yanlin, Wang Lixia
    Chinese Journal of Antituberculosis. 2024, 46(10):  1198-1208.  doi:10.19982/j.issn.1000-6621.20240382
    Abstract ( 615 )   HTML ( 73 )   PDF (4332KB) ( 747 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To systematically description and analyze the epidemiological characteristics of reported cases of pulmonary tuberculosis (TB) in China from 1997 to 2023, and to provide scientific evidences for development and improvement of TB prevention and control strategies in China. Methods: The incidence data of pulmonary TB from 1997 to 2023 were collected from the National Epidemic Data Collection, Disease Surveillance and Statistics Report, and Infectious Disease Reporting Information Management System. The temporal and spatial trends of reported incidence of pulmonary TB in the whole country and various regions, the distribution characteristics of different gender, age and occupation group,and the positive rate of etiology in TB patients were analyzed. Results: From 1997 to 2023, a total of 21.9066 million pulmonary TB cases were reported in China, increasing from 418234 in 1997 to 1259308 in 2005, and then decreasing to 613091 in 2023. From 2005 to 2023, the reported incidence rate of pulmonary TB showed an decreasing trend (AAPC=-4.78%, 95%CI: -5.44% to -4.13%, P<0.001), and the decline was slower in the western region (AAPC=-4.42%, 95%CI: -5.77% to -2.89%, P<0.001). From 1997 to 2023, the male-to-female ratio of reported TB cases in China was 2.22∶1, the proportion of children younger than 15 years showed a decreasing trend (AAPC=-5.74%, 95%CI: -6.01% to -5.50%, P<0.001), and the proportion of elderly aged ≥65 years showed an increasing trend (AAPC=3.80%, 95%CI: 3.61% to 3.99%, P<0.001). The top five occupations reporting the number of cases were farmers, animal keepers and fishermen (61.50%,13421197/21822416), homemakers and unemployed persons (9.32%,2033078/21822416), workers (5.89%,1285335/21822416), students (5.44%,1186104/21822416) and retired persons (4.69%,1022406/21822416). The etiological positive rate of reported TB patients in 2023 was 67.08%(392569/585187). Conclusion: Since 1997, the reported incidence of pulmonary TB in China increased first and then decreased, reflecting the effect of effective TB prevention and control measures in different periods. In the future, different strategies should be implemented according to the epidemic characteristics of TB in different regions and populations, and the application of new technologies and measures should be promoted to accelerate the end of the TB epidemic.

    Research status and future prospects of latent tuberculosis infection from a bibliometric perspective
    Yang Yixuan, Xin Jibin, Ruan Qiaoling, Ying Jun, Zhang Wenhong
    Chinese Journal of Antituberculosis. 2024, 46(10):  1209-1218.  doi:10.19982/j.issn.1000-6621.20240235
    Abstract ( 217 )   HTML ( 9 )   PDF (4323KB) ( 228 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: This study employs bibliometric analysis to examine the literature on latent tuberculosis infection (LTBI), with the goal of providing researchers with a comprehensive understanding of the current research landscape and future trends. Methods: The analysis was conducted using the expanded version of the Science Citation Index in the Web of Science Core Collection database, with the search field set to the topic. The primary keywords included ‘Latent Tuberculosis’ ‘Latent TB’ and ‘LTBI’. The literature search was conducted on May 13, 2024, and the publication period was restricted to 2014—2023. Only original research articles and review papers published in English were included, resulting in a total of 4210 relevant publications. VOSviewer software was employed to visualize the data and perform an in-depth analysis of the LTBI research field, focusing on publication trends, journal analysis, highly cited papers, international research collaboration networks, and keyword clustering. Results: Since the World Health Organization introduced its LTBI strategy in 2015, the topic has garnered sustained attention from the global academic community. From January 2014 to December 2024, we identified 4210 relevant articles, which collectively received 74324 citations, averaging 17.65 citations per article. The United States led in the number of publications (1314 articles, 31.21%), followed by China (587 articles, 13.94%). Analysis of international research cooperation networks revealed that latent tuberculosis infection research is marked by close collaboration among countries and regions, with the United States, China, the United Kingdom, India, and Italy taking leading roles. Keyword clustering indicated that the primary research focuses in this field currently include immunological mechanisms, comprehensive management, LTBI in the context of rheumatic diseases, and LTBI screening. Conclusion: This study highlights the current research landscape and future trends in the field of LTBI, offering valuable insights and references for research institutions and scholars.

    Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Fujian Province from 2008 to 2022
    Du Yongcheng, Lin Shufang, Dai Zhisong, Lin Jian
    Chinese Journal of Antituberculosis. 2024, 46(10):  1219-1226.  doi:10.19982/j.issn.1000-6621.20240168
    Abstract ( 146 )   HTML ( 22 )   PDF (960KB) ( 154 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the incidence and epidemic characteristics of pulmonary tuberculosis (PTB) among children aged 0-14 from 2008 to 2022 in Fujian Province, and to provide evidence for the prevention and control strategy of childhood tuberculosis. Methods: The incidence data and population data of PTB among children aged 0-14 in Fujian Province from 2008 to 2022 were extracted from the National Health Security Information Project Disease Prevention and Control Information System-Surveillance Management System and Basic Information System. The disease distribution and etiological examination results were analyzed using retrospective description and Joinpoint regression model. Results: From 2008 to 2022, a total of 1430 PTB cases among children aged 0-14 were reported in Fujian Province, accounting for 0.46% of the overall PTB patients (1430/307833). The average annual reported incidence of PTB in children during the 15-year period was 1.44/100000 (1430/99435600), which was generally stable (AAPC=-5.69%,t=-1.618,P=0.106). The average annual reported incidence of PTB among children aged 10-14 was 3.20/100000 (929/29051400), which was higher than that among children aged 0-4 and 5-9 (χ2=887.195,P<0.001). The reported incidence of PTB among children aged 0-4 showed a significant downward trend (AAPC=-8.55%,t=-2.438,P=0.015). The reported incidence of tuberculosis among children aged 5-9 and 10-14 showed a phased change, showing a significant upward trend in 2010—2022 (APC=3.28%,t=2.416,P=0.036) and 2010—2019 (APC=7.57%,t=2.787, P=0.027), respectively. There was no monthly periodic change in the incidence of PTB in children reported within each year. The average etiologically positive rate in children with PTB was 35.24% (504/1430) which showed an increasing trend from year to year ($\chi_{\text{trend}}^2$=55.195,P<0.001). The highest and lowest annual reported incidence of PTB among children were in Ningde City and Longyan City, respectively, and the difference was statistically significant (χ2=169.688,P<0.001). Except for Putian City (AAPC=-6.77%,t=-2.957, P=0.011) and Nanping City (AAPC=-5.67%,t=-2.195,P=0.047), where the reported incidences showed significant downward trends, incidences in the rest of cities were stable. Conclusion: From 2008 to 2022, the reported incidence of PTB in children in Fujian Province was at a low level, relatively stable through years, with an increase among children aged 5-9 and 10-14 in recent years, while the incidence in Ningde City was higher and the downward trend was not obvious, which should be paid attention to.

    Spatial and temporal correlation analysis of school pulmonary tuberculosis prevalence and contact screening results in Guizhou Province from 2022 to 2023
    Liao Long, Chen Huijuan, Li Jinlan, Wang Yun, He Yuying, Huang Aiju
    Chinese Journal of Antituberculosis. 2024, 46(10):  1227-1235.  doi:10.19982/j.issn.1000-6621.20240214
    Abstract ( 174 )   HTML ( 22 )   PDF (3470KB) ( 217 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To analyze the spatial and temporal distribution differences and epidemiological trends of the screening results of registered pulmonary tuberculosis cases and contacts in schools from 2022 to 2023, to identify the key times and regions for tuberculosis prevention and control in schools of Guizhou Province, providing scientific basis for formulating and optimizing strategies for tuberculosis prevention and control in schools of Guizhou Province. Methods: Data on tuberculosis cases reported in schools of Guizhou Province for 2022—2023 were collected using the “China Disease Prevention and Control Information System—Tuberculosis Information Management System”, while data on contacts of tuberculosis cases were gathered through the “Guizhou Disease Prevention and Control Cloud PlatformSchool Tuberculosis Management System”. Descriptive epidemiological methods were used to analyze the epidemiological characteristics of school tuberculosis cases and detected cases from their contacts. The trend of monthly average tuberculosis case registration rates (and detection rates from contact screening) was analyzed using Joinpoint. Global and local spatial autocorrelation analyses were conducted using ArcGIS 10.6, and spatiotemporal scan analysis was performed using SaTScan 9.7. Results: From 2022 to 2023, Guizhou Province reported 6310 school tuberculosis cases, with an annual average registration rate of 29.82/100000 (6310/21161926) and a bacteriological positivity rate of 44.83% (2829/6130). A total of 255801 school contacts were screened, identifying 288 tuberculosis cases, resulting in a detection rate of 0.11%. Joinpoint regression analysis revealed the monthly average registration rate for tuberculosis cases showed an overall increase (AAPC=0.60%, 95%CI:-8.50% to 10.60%, P=0.906) per month, while the monthly average detection rate among contacts decreased (AAPC=-17.45%, 95%CI: -31.43% to -0.62%,P=0.043) per month. Local spatial autocorrelation analysis identified 8 counties (districts) as “high-high clusters” for tuberculosis cases, including areas in Bijie Prefecture (Qixingguan District, Dafang County, Qianxi City, Hezhang County, Zhijin County, Nayong County) and Liupanshui Prefecture (Zhongshan District, Shuicheng District). For contact cases, 2 counties (districts) were identified as “high-high clusters”, located in Bijie Prefecture (Qixingguan District) and Liupanshui Prefecture (Zhongshan District). Spatiotemporal scan analysis showed that tuberculosis cases centered around Dafang County, involving 4 counties (districts)(RR=1.63, LLR=62.76, P<0.001), while contact cases centered in Xixiu District, covering 16 counties (districts)(RR=6.65, LLR=9.74, P<0.001). Conclusion: The registered incidence of tuberculosis in schools in Guizhou Province was relatively high, and the “high-high” cluster area of school tuberculosis was mainly located in Bijie Prefecture, and more tuberculosis patients were detected during tuberculosis contacts screening at the beginning of the year.

    The value of CT-based deep learning models in differentiating nontuberculous mycobacterial lung disease from pulmonary tuberculosis
    Li Wenting, Wang Li, Fang Yong, Gu Jin, Sha Wei
    Chinese Journal of Antituberculosis. 2024, 46(10):  1236-1242.  doi:10.19982/j.issn.1000-6621.20240263
    Abstract ( 193 )   HTML ( 13 )   PDF (2282KB) ( 295 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To develop and assess the effectiveness of various deep learning networks based on CT imaging for distinguishing nontuberculous mycobacterial lung disease (NTM-LD) from pulmonary tuberculosis (PTB). Methods: A retrospective analysis was performed on chest CT images from patients with PTB and NTM-LD at the Tuberculosis Department of Shanghai Pulmonary Hospital between October 2019 and December 2022. The data were divided into two groups: the PTB group (197 cases) and the NTM-LD group (212 cases). Each group was split into training and testing sets in an 8∶2 ratio. Diagnostic models were developed using several deep learning networks, including ResNeXt, ResNet, Transformer, SENet, ShuffleNet, Swin-Transformer, and DenseNet. The diagnostic performance of the models was assessed based on the area under the curve (AUC), accuracy, sensitivity, and specificity. The performance of the optimal model was then compared with that of three radiologists with varying years of experience, using the testing set. Results: The AUC values of the ResNeXt, ResNet, Transformer, SENet, ShuffleNet, Swin-Transformer, and DenseNet models on the training set were 0.894, 0.839, 0.864, 0.816, 0.841, 0.831, and 0.829, respectively. On the test set, the AUC values were 0.826, 0.816, 0.817, 0.811, 0.784, 0.771, and 0.735, respectively. In the test set, the ResNeXt model, with an AUC of 0.826, outperformed both a moderately experienced doctor (AUC: 0.679) and a less experienced doctor (AUC:0.663), with Z values of 2.035 and 2.242, respectively (P<0.05). Conclusion: The deep learning network model based on chest CT images is a rapid, simple, and non-invasive diagnostic tool, demonstrating excellent performance in distinguishing NTM-LD from PTB.

    Study on detection methods of mixed infection with Mycobacterium tuberculosis complex and nontuberculous mycobacteria based on BACTEC MGIT 960 culture
    Chen Zhenhua, Guo Jingwei, Wang Jue, Hu Peilei, Yi Songlin, Liu Yi, Tan Yunhong
    Chinese Journal of Antituberculosis. 2024, 46(10):  1243-1249.  doi:10.19982/j.issn.1000-6621.20240128
    Abstract ( 157 )   HTML ( 11 )   PDF (856KB) ( 150 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To investigate the detection methods for mixed infections with Mycobacterium tuberculosis complex (MTBC) and nontuberculous mycobacteria (NTM), and provide reference for clinical diagnosis and treatment of mixed infections. Methods: Bacterial suspensions with three different initial concentrations (10-2 mg/ml, 10-4 mg/ml, and 10-6 mg/ml) were prepared respectively using MTBC standard strains (H37Rv) and three NTM species (M.abscessus, M.avium, and M.intracellulare). The bacterial suspensions at same initial concentrations of NTM and MTBC were mixed in nine different ratios (namely each NTM were mixed with H37Rv in a ratio of 1∶99, 5∶95, 10∶90, 20∶80, 50∶50, 80∶20, 90∶10, 95∶5, and 99∶1) to create a total of 81 simulated mixed infection specimens, which including three infection models: M.abscessus plus H37Rv, M.avium plus H37Rv, and M.intracellulare plus H37Rv. All mixed infection specimens were incubated in the MGIT 960 system and then tested using four methods: MPB64 antigen assay, p-nitrobenzoic acid (PNB) growth assay, fluorescent PCR melting curve method, and real-time fluorescence thermostatic amplification. Results: All 81 specimens from 3 mixed infection models reported positive within 34 days. Among them, 3 specimens (3.7%, 3/81) tested positive for the MPB64 antigen, while 78 specimens (96.3%, 78/81) tested positive for the PNB growth assay. By using the fluorescent PCR melting curve method, 64 specimens (79.0%, 64/81) were detected as corresponding NTM alone, 3 specimens (3.7%, 3/81) were MTBC alone, and 14 specimens (17.3%, 14/81) were both NTM and MTBC. MTBC was detected in 67 specimens (82.7%, 67/81) by using the thermostatic amplification real-time fluorescence method. Conclusion: The clinical specimens that were cultured and reported positive by BACTEC MGIT 960, MPB64 antigen test and PNB growth assay were recommended for preliminary assessment. If NTM growth in the MGIT tube is observed, a molecular biological method is recommended for identifying NTM. At the same time, another molecular method specific for MTBC nucleic acid can be used for the culture medium examination to avoid missed detection of MTBC.

    Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance
    Li Jing, Jiang Qi, Jiang Yuan, Shen Xin
    Chinese Journal of Antituberculosis. 2024, 46(10):  1250-1258.  doi:10.19982/j.issn.1000-6621.20240166
    Abstract ( 206 )   HTML ( 12 )   PDF (906KB) ( 230 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To evaluate the efficacy of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex (MTBC) and rifampicin resistance in sputum samples, and to provide feasibility data for further development of a multi-center clinical trial of MTBC and rifampicin resistance nucleic acid detection kit. Methods: Using prospective research method, three sputum specimens (immediate sputum, night sputum and morning sputum) from each of 205 patients with suspected pulmonary tuberculosis who met the enrollment criteria and were initially diagnosed at the pulmonary outpatient clinics of three designated tuberculosis hospitals in Shanghai from December 2021 to August 2022 were collected, and sputum smears, BACTEC MGIT 960 (MGIT 960), GeneXpert MTB/RIF (Xpert) and PCR fluorescent probe method were performed separately to evaluate the efficacy of PCR fluorescence probe method for detecting MTBC and rifampicin resistance in sputum samples. In addition, 96 clinical strains identified as MTBC (47 rifampicin-resistant strains and 49 rifampicin-sensitive strains) stored in the tuberculosis laboratory of Shanghai Center for Disease Control and Prevention were randomly selected to be tested for rifampicin resistance by PCR fluorescent probe method and Xpert, then rifampicin resistance-related gene mutations identified by the two methods were analyzed. Results: Among 205 patients with suspected pulmonary tuberculosis, the MTBC detection rate by PCR fluorescent probe assay was 22.44% (46/205), which was not statistically different from MGIT 960 (21.95% (45/205); χ2=0.014, P=0.904), Xpert (20.98% (43/205); χ2=0.129, P=0.719), and sputum smear (16.10% (33/205); χ2=2.650, P=0.104). Based on clinical diagnosis, the sensitivities (95%CI) of PCR fluorescent probe method, Xpert, MGIT 960 and sputum smear for the detection of MTBC were 48.10% (36.93%-59.56%), 48.10% (36.93%-59.56%), 50.63% (39.23%-61.97%) and 40.51% (29.79%-52.15%), the specificities (95%CI) were 93.65% (87.47%-97.12%), 96.03% (90.52%-98.53%), 96.03% (90.52%-98.53%) and 99.21% (95.01%-99.96%), the coincidence rates were 76.10% (156/205), 77.56% (159/205), 78.54% (161/205) and 76.59% (157/205), and the Kappa values were 0.453, 0.482, 0.507 and 0.446, respectively. There was no significant difference between MTBC detection rate of PCR fluorescent probe method (10.73% (19/177)) and Xpert (8.47% (15/177); χ2=0.793, P=0.373) on testing smear-negative and extremely low-grade positive samples. Six rifampicin resistance gene mutations out of 46 MTBC were detected by PCR fluorescence probe method, and the mutation rate was 13.04% (6/46), while only 1 gene mutation out of 43 MTBC was detected by Xpert, and the mutation rate was 2.33% (1/43). Among 96 clinical strains, 56 strains were found to have rifampicin resistance gene mutation by both methods. Except for mutation types of two probes, the mutation types of all other probes were consistent, and most of them occurred in probe E (529-533) and FAM channel (531/533 mutation). Conclusion: Based on clinical diagnosis, the efficacy of PCR fluorescent probe method in detecting MTBC is basically equivalent to MGIT 960, Xpert and sputum smear, and its efficacy is consistent with Xpert in detecting rifampicin resistance of MTBC clinical strains. It is considered that PCR fluorescent probe method is not only a new technology equivalent to Xpert detection function, but also has the advantages of operation simplicity, lower price, real one-piece and fully enclosed testing platform. It is suggested that PCR fluorescent probe method should be further optimized in the process of clinical popularization to improve detection rate of MTBC, and multi-center clinical trials should be carried out to verify the study.

    Nontuberculous mycobacterium parotid lymphadenitis in children: report of 3 cases and literature review
    Li Cuiping, Chen Pinru, Xue Lijing, Zheng Shengkun
    Chinese Journal of Antituberculosis. 2024, 46(10):  1259-1265.  doi:10.19982/j.issn.1000-6621.20240177
    Abstract ( 105 )   HTML ( 5 )   PDF (2671KB) ( 211 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Objective: To summarize and analyze the clinical features, imaging findings, pathological characteristics, treatment, and prognosis of nontuberculous mycobacterium (NTM) parotid lymphadenitis in children, with the aim of enhancing the understanding of this condition. Methods: A retrospective analysis was conducted on the clinical data of three children diagnosed with nontuberculous mycobacterium (NTM) parotid lymphadenitis at Guangzhou Chest Hospital between December 2020 and December 2023. The data included general information (age, gender, height, body mass, BCG vaccination history, tuberculosis contact history, etc.), clinical manifestations, laboratory tests, imaging findings, surgical and pathological results, treatment options, and prognosis. A search using the terms ‘non-tuberculous mycobacteria, children, lymphadenitis’ in the PubMed database from 2004 to 2023 retrieved 189 cases. When the search was refined to ‘non-tuberculous mycobacteria, children, lymphadenitis, parotid gland,’ only 5 relevant references were found in PubMed. Additionally, searches using the terms ‘non-tuberculous mycobacterium, children, lymphadenitis’ and ‘non-tuberculous mycobacterium, children, parotid gland’ in the Wanfang and CNKI databases yielded no relevant Chinese literature. A total of 53 and 50 cases, respectively, were reviewed. Results: Of the 53 patients, 32 were male and 21 were female, with an average age of (2.71±1.52)years. The primary clinical manifestation was recurrent neck and facial swelling, typically presenting as painless lymphadenopathy. The duration of illness ranged from 1 month to 1 year. Most patients did not exhibit fever or significant respiratory symptoms such as coughing. Imaging studies, including color Doppler ultrasound, CT, and MRI, revealed parotid gland abscesses. Twenty-five cases tested positive for the tuberculin skin test, and acid-fast staining was positive in pus and lesion tissues in 10 cases. Pathological examination showed chronic granulomatous inflammation. Nucleic acid testing for the nontuberculous mycobacterium complex was positive, while acid-fast staining was negative. Both pus and lesion tissues tested negative for GeneXpert MTB/RIF, and the blood gamma interferon release assay was also negative. After surgical intervention combined with azithromycin, rifampicin, ethambutol, and other anti-infective treatments, the patients recovered without recurrence. Conclusion: When infants present with recurrent unilateral painless enlargement of the parotid gland or preauricular lymph nodes, along with skin discoloration from flushing to violet, and without systemic symptoms such as fever, cough, weight loss, or night sweats, and when conventional antibiotic treatment is ineffective, blood IGRA is negative, and there is no history of active pulmonary tuberculosis, clinicians should be alert to the possibility of NTM parotid gland lymphadenitis. Timely surgical resection combined with appropriate anti-infective therapy is recommended.

    Review Articles
    Research progresses of risk factors for tuberculosis in the elderly
    Zhang Mengdi, Wang Xin, Zheng Wenjing, Wang Qiqi, Li Tao, Wang Ni, Liu Jianjun, Huang Fei, Yao Hongyan
    Chinese Journal of Antituberculosis. 2024, 46(10):  1266-1272.  doi:10.19982/j.issn.1000-6621.20240255
    Abstract ( 194 )   HTML ( 20 )   PDF (944KB) ( 169 )   Save
    References | Related Articles | Metrics

    As China experiences rapid aging and faces specific challenges among its elderly population, including reduced immune function, malnutrition, co-morbidities, and limited access to health services, tuberculosis (TB) among the elderly has become a critical focus for TB prevention and control. Examining the prevalence of TB in the elderly and identifying its associated risk factors are essential for effective etiological prevention, targeted prevention and control strategies, and the reduction of TB incidence among the elderly. This paper analyzed the prevalence of TB in the elderly in China and reviewed relevant literature on its risk factors. The aim was to provide a basis for the formulation of future TB prevention and control strategies and to support related research.

    Advances in the host-directed therapy of tuberculosis
    Yan Hongxuan, Yuan Jinfeng, Wang Yilin, Pang Yu, Gao Mengqiu
    Chinese Journal of Antituberculosis. 2024, 46(10):  1273-1282.  doi:10.19982/j.issn.1000-6621.20240207
    Abstract ( 144 )   HTML ( 9 )   PDF (1794KB) ( 420 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Host-directed therapy (HDT) is a new adjuvant therapy for tuberculosis, which aims at host cells rather than pathogens via modulating host immune response to combat infections. When combined use of HDT with anti-tuberculosis drugs, it provides benefits to enhance the efficacy of chemotherapy, shorten the treatment duration, decrease immunopathological damage, and prevent the emergence of drug resistance. This paper reviews the common mechanisms of HDT, and summarizes several HDT drug candidates that are currently being studied, in order to provide new insight for developing new and effective anti-tuberculosis therapies.

    Overview of genomic research on Mycobacteriophages
    Liu Kejun, Zhang Haipeng, Wang Peng
    Chinese Journal of Antituberculosis. 2024, 46(10):  1283-1292.  doi:10.19982/j.issn.1000-6621.20240217
    Abstract ( 181 )   HTML ( 10 )   PDF (1709KB) ( 166 )   Save
    Figures and Tables | References | Related Articles | Metrics

    Mycobacterial infections represent a significant global health burden, with multidrug-resistant tuberculosis (MDR-TB) posing a critical public health crisis and a serious threat to health security. Identifying effective strategies to combat mycobacterial infections has become an urgent priority. Mycobacteriophages, viruses that specifically target and lyse mycobacteria, offer a promising approach by effectively killing the host bacteria. litating the advancement of mycobacteriophage applications. This review explores the general genomic characteristics, gene functions, and expression patterns of mycobacteriophages, offering a foundation for further research in this field.

Monthly, Established in Novembar 1934
ISSN 1000-6621
CN 11-2761/R

    Responsible Institution
    China Association for Science and Technology
    Sponsor
    Chinese Antituberculosis Association
    42 Dongsi Xidajie,Beijing 100710,China
    Editing
    Editorial Board of Chinese Journal of Antituberculosis
    5 Dongguang Hutong,Beijing 100035,China
    Tel(Fax): 0086-10-62257587
    http://www.zgflzz.cn
    Email: zgfIzz@163.com
    Editor-in-chief
    WANG Li-xia(王黎霞)
    Managing Director
    Ll Jing-wen(李敬文)
    Publishing
    Chinese Journal of Antituberculosis Publishing House
    5 Dongguang Hutong, Beijing 100035,China
    Tel(Fax):0086-10-62257257
    Email: zgflzz@163.com
    Printing
    Tomato Cloud Printing (Cangzhou) Co., Ltd.
    Overseas Distributor
    China International BookTrading Corporation
    P.O. Box 399,Beijing 100044,China
    Code No.M3721
Wechat